Bio-Techne (TECH) Interest Coverage Ratio (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.29% |
| Dec 31, 2025 | 54.44% |
| Sep 30, 2025 | 248.27% |
| Jun 30, 2025 | -156.80% |
| Mar 31, 2025 | -12.64% |
| Dec 31, 2024 | 20.13% |
| Sep 30, 2024 | 0.62% |
| Jun 30, 2024 | 9.18% |
| Mar 31, 2024 | 90.55% |
| Dec 31, 2023 | -23.10% |
| Sep 30, 2023 | -55.29% |
| Jun 30, 2023 | -56.48% |
| Mar 31, 2023 | 103.62% |
| Dec 31, 2022 | 93.93% |
| Sep 30, 2022 | -53.80% |
| Jun 30, 2022 | -11.34% |
| Mar 31, 2022 | 68.87% |
| Dec 31, 2021 | 15.85% |
| Sep 30, 2021 | -11.01% |
| Jun 30, 2021 | -19.23% |
| Mar 31, 2021 | 81.37% |
| Dec 31, 2020 | 27.95% |
| Sep 30, 2020 | 30.57% |
| Jun 30, 2020 | -20.08% |
| Mar 31, 2020 | 40.31% |
| Dec 31, 2019 | 18.97% |
| Sep 30, 2019 | -17.47% |
| Jun 30, 2019 | -10.33% |
| Mar 31, 2019 | 47.79% |
| Dec 31, 2018 | 18.65% |
| Sep 30, 2018 | 156.72% |
| Jun 30, 2018 | -151.51% |
| Mar 31, 2018 | 62.46% |
| Dec 31, 2017 | -10.74% |
| Sep 30, 2017 | -37.40% |
| Jun 30, 2017 | -95.24% |
| Mar 31, 2017 | 87.36% |
| Dec 31, 2016 | -59.35% |
| Sep 30, 2016 | 453.54% |
| Jun 30, 2016 | -4.89% |
| Mar 31, 2016 | 7.88% |
| Dec 31, 2015 | 30.91% |
| Sep 30, 2015 | -29.38% |
| Jun 30, 2015 | 2.30% |
| Mar 31, 2015 | 20.35% |
| Dec 31, 2014 | -30.12% |